Korean stem cell investigation expands to another researcher, and more papers

Last month, we brought you the story of Soo-Kyung Kang, a Seoul National University stem cell researcher who has now retracted four papers amidst questions about image manipulation in a total of 14 studies. That story has drawn a great deal of attention in Korea, with comparisons to the Woo-Suk Hwang scandal, and has even led to a … Continue reading Korean stem cell investigation expands to another researcher, and more papers

Endocrinologist Shigeaki Kato resigns amidst University of Tokyo misconduct investigation

Shigeaki Kato, an endocrinology researcher at the University of Tokyo who retracted a paper late last month, has resigned amidst an investigation into whether he committed misconduct, Japanese media outlets are reporting. According to the reports, the university has been investigating Shigeaki Kato and his group, affiliated with the Institute of Molecular and Cellular Biosciences, … Continue reading Endocrinologist Shigeaki Kato resigns amidst University of Tokyo misconduct investigation

Cell runs a lengthy correction, rather than retraction, for image problems

The journal Cell has an interesting — and somewhat puzzling — correction this month that we’ll add to our “mega-correction” file. At issue is a paper, published in October, from the lab of Harvard’s Stephen Elledge, a noted genetics researcher, whose first author is a post-doc there named Michael Emanuele. According to the notice, Emanuele (singled … Continue reading Cell runs a lengthy correction, rather than retraction, for image problems

Resveratrol fraud case update: Dipak Das loses editor’s chair, lawyer issues statement refuting all charges

Many Retraction Watch readers will now be familiar with the case of Dipak Das, the resveratrol researcher about whom the University of Connecticut issued a voluminous report yesterday — summary here — detailing 145 counts of data fabrication and falsification. This has been a fast-moving story, so we wanted to highlight a number of updates to our original post, and offer a few … Continue reading Resveratrol fraud case update: Dipak Das loses editor’s chair, lawyer issues statement refuting all charges

UConn resveratrol researcher Dipak Das fingered in sweeping misconduct case

The University of Connecticut, in what clearly seems like an attempt to get ahead of damaging news, has announced an “extensive” investigation into research misconduct involving one of its scientists, Dipak K. Das. According to a press release, the university has notified 11 journals that published Das’ work about the alleged fraud. One area of … Continue reading UConn resveratrol researcher Dipak Das fingered in sweeping misconduct case

Bulfone-Paus retraction count grows to 13 with one in Transplantation

Silvia Bulfone-Paus, the Borstel Institute researcher who was forced to step down as institute director and has already retracted 12 papers, has retracted another, this one in Transplantation. Here’s the text of the notice:

Another Bulfone-Paus paper under review, this one in Blood

Blood tells Retraction Watch that they are reviewing a 1999 paper co-authored by Silvia Bulfone-Paus, who has already retracted 12 papers in other journals. The study, “Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15,” has been cited 124 times, according to Thomson Scientific’s Web of Knowledge. Its corresponding author is Tiziana Musso, of … Continue reading Another Bulfone-Paus paper under review, this one in Blood

Hazardous materials: Elsevier retracts 11 chemistry papers from Brazilian group, citing fraud

The publisher Elsevier has announced that it is retracting 11 papers from a team of Brazilian researchers over concerns that the scientists committed fraud in the studies. The notice is pegged to an October 2009 article in the Journal of Colloid and Interface Science titled “Immobilization of 5-amino-1,3,4-thiadiazole-thiol onto kanemite for thorium(IV) removal: Thermodynamics and … Continue reading Hazardous materials: Elsevier retracts 11 chemistry papers from Brazilian group, citing fraud